INT220080

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.01
First Reported 2007
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 1.06
Pain Relevance 1.23

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleus (SSX3) intracellular (SSX3)
SSX3 (Homo sapiens)
Pain Link Frequency Relevance Heat
analgesia 12 99.96 Very High Very High Very High
Central nervous system 19 99.54 Very High Very High Very High
Pain 88 99.24 Very High Very High Very High
agonist 11 99.20 Very High Very High Very High
Cannabinoid receptor 2 94.08 High High
Cannabinoid 5 86.36 High High
Lasting pain 22 83.44 Quite High
Endocannabinoid 1 79.40 Quite High
Inflammation 32 79.36 Quite High
Periaqueductal grey 1 76.60 Quite High
Disease Link Frequency Relevance Heat
Pain 118 99.24 Very High Very High Very High
Sleep Disorders 6 92.12 High High
Dizziness 1 91.60 High High
INFLAMMATION 40 79.36 Quite High
Stress 1 77.96 Quite High
Urological Neuroanatomy 1 76.60 Quite High
Catalepsy 1 64.32 Quite High
Frailty 48 56.36 Quite High
Disease 6 55.52 Quite High
Arthritis 4 50.00 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Thus, localized administration of HU210 or oral administration of CB1 agonists with limited CNS availability, such as CT-3 (ajulemic acid), produced analgesia both in pain models [42,43] and in the clinic at a dose that causes minimal CNS side effects [44].
Gene_expression (produced) of CT-3 associated with pain, agonist, central nervous system and analgesia
1) Confidence 0.01 Published 2007 Journal Arthritis Res Ther Section Body Doc Link PMC2206352 Disease Relevance 1.06 Pain Relevance 1.23

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox